Indoco Remedies Share price

Q: How to buy Indoco Remedies Share at Choice?

To buy Indoco Remedies stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Indoco Remedies, choose your preferred order type, and place the trade.

INDOCO

Healthcare Small Cap

211.04

1.38 (0.66%)

NSE

BSE

Last updated on 1 Jun, 2026 | 12:03 IST

BUYSELL

Today's High

215.50

Today's Low

209.09

52 Week Low

162.19

52 Week High

349.80

Free Demat with Zero AMC*

Indoco Remedies Chart

ChartIQ

TradingView

Indoco Remedies Share Key Metrics

Volume

60560.00

Market Cap

1935.24 CR

LTQ@LTP

10@211.04

ATP

212.69 Var Margin

21.79 %

Circuit Range

167.73-251.59

Delivery %

44.95 %

Value

1.29 CR

ASM/GSM

No

Market Lot

1

Summary

Indoco Remedies share price is ₹211.04 as of 1 Jun, 2026. The stock Indoco Remedies intraday movement has stayed between ₹209.09 and ₹215.50, while on a 52-week basis,Indoco Remedies price 52 week high is ₹349.80 & its 52 week low is ₹162.19.

In terms of trading activity, Indoco Remedies has recorded a volume of 60560 shares, The Indoco Remedies has a market cap of ₹92303605 CR. The stock’s Average Traded Price (ATP) stands at ₹212.69, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹211.04.

Indoco Remedies operates within a circuit range of ₹167.73 – ₹251.59, with a Value of ₹1.29 CR. The Delivery Percentage for the day is 44.95%. Additionally, Indoco Remedies currently falls under the No framework, and trades with a market lot size of 1.

Indoco Remedies Fundamentals

P/E Ratio

0

P/B Ratio

2.06

Div. Yield

0.1

Sector P/E

69.96

Sector P/B

3.01

Sec. Div. Yield

0.55

Indoco Remedies Resistance and Support

Pivot 212.76

Resistance

First Resistance

216.91

Second Resistance

224.15

Third Resistance

228.3

Support

First Support

205.52

Second Support

201.37

Third Support

194.13

Indoco Remedies Shareholding Pattern

2016-17
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27
2019-20
2018-19

Total Promoters

Segment

Percent

Total Promoters

58.69%

Mutual Fund

17.28%

Insurance

0.06%

Foreign Institutional Investors

1.23%

Domestic Institutional Investors

0.73%

Retail

22.01%

Others

0%

Total Promoters

MAR '22

58.69%

JUN '22

58.69%

SEP '22

58.69%

DEC '22

58.69%

Indoco Remedies Corporate Actions

Date	Agenda
2026-05-07	Audited Results & Final Dividend
2026-02-03	Quarterly Results
2025-11-06	Quarterly Results
2025-07-24	Quarterly Results
2025-05-22	Audited Results & Final Dividend
2025-01-21	Quarterly Results

Indoco Remedies News

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Indoco Remedies Ltd.'s Baddi Plant-III has received EU GMP certification from the German Health Authority (Berlin). This certification, following an inspection from April 22-27, 2026, confirms the facility's adherence to Good Manufacturing Practice requirements, enhancing its market access.

May 28 2026 16:23:44

Indoco Remedies Limited

Indoco Remedies received EU GMP certification for its Baddi Plant-III from the German Health Authority. This approval confirms the facility's compliance with Good Manufacturing Practice requirements, enhancing its market access in Europe.

May 28 2026 16:18:33

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

Indoco Remedies completed the slump sale of its Ophthalmic Division to Sunways (India) Private Limited on May 18, 2026. This strategic transfer encompasses various international territories, including India.

May 18 2026 20:14:58

Indoco Remedies Limited

Indoco Remedies completed the transfer of its Ophthalmic Division to Sunways (India) Private Limited via a slump sale. This divestment covers operations in India and several African territories.

May 18 2026 20:11:10

Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Indoco Remedies' Baddi Unit-I manufacturing facility has successfully received EU GMP certification from the Malta Medicines Authority. This certification confirms compliance with Good Manufacturing Practice requirements for its solid oral dosage form production.

May 14 2026 11:02:53

Name	Position
Suresh G Kare	Chairman
Aditi Panandikar	Managing Director

Indoco Remedies Similar Stocks

Dr Agarwals Eye Hospital Ltd.

5050.00

83.50 (1.68%)

Hikal Ltd.

193.94

-1.34 (0.69%)

Kwality Pharmaceuticals Ltd.

2250.00

-59.60 (2.58%)

Morepen Laboratories Ltd.

47.85

4.61 (10.66%)

Sai Parenteral's Ltd.

531.60

45.70 (9.41%)

Shalby Ltd.

172.40

3.59 (2.13%)

Krsnaa Diagnostics Ltd.

546.65

-2.80 (0.51%)

Sakar Healthcare Ltd.

856.85

60.35 (7.58%)

NGL Fine-Chem Ltd.

2911.80

126.70 (4.55%)

Windlas Biotech Ltd.

836.20

3.10 (0.37%)

Indoco Remedies FAQs

The Buying Price of Indoco Remedies share is 211.04 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Indoco Remedies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Indoco Remedies, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Indoco Remedies shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Indoco Remedies shares is 2.06. Useful to assess the stock's value relative to its book value.

To assess Indoco Remedies’s valuation compare Sector P/E, P/B which are 69.96 & 3.01 with sector averages, along with growth rates and financial metrics.

The Market Cap of Indoco Remedies is 1935.24 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Indoco Remedies share price is 349.80 & 162.19. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Indoco Remedies belongs to the Healthcare sector.